N-[[(5-methyl-3-phenylisoxazol-4-yl)phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration

John J. Talley, Stephen R. Bertenshaw, David L. Brown, Jeffery S. Carter, Matthew J. Graneto, Michael S. Kellogg, Carol M. Koboldt, Jinhua Yuan, Yan Y. Zhang, Karen Seibert

Research output: Contribution to journalLetterpeer-review

230 Scopus citations
Original languageEnglish
Pages (from-to)1661-1663
Number of pages3
JournalJournal of Medicinal Chemistry
Volume43
Issue number9
DOIs
StatePublished - May 30 2000

Cite this